September 4, 2024
TOPLINE: Nearly 80% of patients with metastatic uveal melanoma experienced skin toxicities with tebentafusp, a targeted immunotherapy, according to a study that also suggests that the […]
September 4, 2024
TOPLINE: Prehospital pulse-dose glucocorticoid treatment in patients with ST-segment elevation myocardial infarction (STEMI) does not reduce the final infarct size at 3 months but may improve […]
September 4, 2024
TOPLINE: Nearly 45% of cancer survivors face financial hardship during and after their cancer care, with factors including higher social vulnerability, younger age, lower income, and […]
September 4, 2024
TOPLINE: An impaired central sensitivity to thyroid hormone may be associated with an increased risk for death in patients with chronic kidney disease (CKD) and normal […]
September 4, 2024
TOPLINE: Higher rheumatoid arthritis (RA) disease activity is associated with an accelerated kidney function decline and increased risk for chronic kidney disease (CKD) stages G3a and […]
September 4, 2024
TOPLINE: Passive distraction through three-dimensional (3D) virtual reality (VR) and two-dimensional (2D) video is equally effective in reducing anxiety in children during the induction of anesthesia […]
September 3, 2024
TOPLINE: Higher thiazide doses are linked to greater reductions in urine calcium levels, which correlate with fewer symptomatic kidney stone events. This association suggests that adjusting […]
September 3, 2024
TOPLINE: Olanzapine improves chemotherapy-induced nausea and vomiting and leads to higher complete response rates, reduced need for rescue medications, and improved quality of life in patients […]
September 2, 2024
TOPLINE: The cumulative incidence of keratinocyte carcinomas (KCs) among childhood cancer survivors (CCS) over 20 years after diagnosis was 1.5% overall and among those exposed to […]